PROGRAMME AT A GLANCE

Day 1
Wednesday 23 June 2010

18.30-19.30 Welcome Addresses
19.30-20.00 Opening Lecture – Disease prevention:
The central dogma of Hippocratic medicine
20.00-20.30 Key Lecture - Immunization and disease control in the European Region

20.30-22.30 Welcome reception in the AKS Conference
Centre gardens.

Day 2
Thursday 24 June 2010

SESSION 1:
VIRAL VACCINE PREVENTABLE DISEASES IN EUROPE

09.00-10.00 Key Talks – Hepatitis B, Polio, Measles, Rubella elimination in Europe
- European experience from HPV vaccination
- Rotavirus Vaccines
- Varicella vaccination in Europe

10.00-10.30 Oral presentations selected from abstracts

10.30-11.00 Coffee break

SESSION 2:
BACTERIAL VACCINE PREVENTABLE DISEASES IN EUROPE

11.00-12.00 Key Talks – Bacterial vaccine preventable diseases in Europe

- Bacterial Vaccine preventable diseases in Europe

- Surveillance of diphtheria, tetanus and pertussis in Europe

- DTap in adolescents, where do we stand?

12.00-12.30 Oral presentations selected from abstracts

12.30-14.00 Lunch

SESSION 3:
BACTERIAL CONJUGATE VACCINES
I) Haemophilus influenzae type B

14.00-14.30 Key talk – Experience with Hib vaccine in the WHO European Region

14.30-15.00 Oral presentations selected from abstracts

15.00-16.30
II) Pneumococcal vaccines
Key Talks
Impact of pneumococcal vaccines in Europe
Experience with 7-valent, 10-valent and 13-valent pneumococcal vaccines
Surveillance of Invasive Pneumococcal Disease in the conjugate vaccine era: Experience from England and Wales

Greek experience of pneumococcal surveillance and immunization programmes
Pneumococcal European Programme

16.30-17.00 Coffee break

17.00-18.00 III) Meningococcal vaccines
Key Talks - European experience with MenC
- Experience with tetravalent meningococcal
conjugate vaccine (MCV4)

18.00-18.30 Oral presentations selected from abstracts

Day 3
Friday 25 June 2010

SESSION 4:
H1N1 IN EUROPE

09.00-10.30 Key talks - H1N1 U.K. experience/global story
- H1N1 Netherlands experience
- H1N1 in EUROPE: The Greek experience
- H1N1 in Ukraine

10.30-11.00 Oral presentations selected from abstracts

11.00-11.30 Coffee break

SESSION 5:
UPDATE ON NEW VACCINE DEVELOPMENTS AND
EUROPEAN IMPLEMENTATION

11.30-12.30 Key talks - Overview of new vaccine initiatives
- New Vaccine implementation in Europe

12.30-13.00 Oral presentations selected from abstracts

13.00-14.30 Lunch

SESSION 6:
DEVELOPMENTS IN THERAPEUTIC ONGOLOGY VACCINES AND IMMUNOTHERAPY

14.30-15.30 Key talks- Immunotherapy in Cancer treatment
-Vaccines in Cancer prevention and treatment

15.30-16.30 Oral presentations selected from abstracts

16.30-16.30 Coffee break

SESSION 7:

CONCLUSIONS

16.30-17.00 General Round Table Discussion surrounding specific issues

17.00-17.30 Immunization programmes and European guidelines

POSTER SESSIONS: To be decided after the abstract submission date.